Trial Profile
An Open Label Phase 2 Study to Assess the Pharmacokinetics of the Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Patients With Parkinson's Disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2021
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Intec Pharma
- 13 Aug 2021 This trial has been completed in Italy.
- 25 Sep 2019 Results published in an Intec Pharma Media Release.
- 25 Sep 2019 According to an Intec Pharma media release, results from the study were presented at he International Congress of Parkinson's and Movement Disorder Society (MDS 2019).